Viewing Study NCT03228303


Ignite Creation Date: 2025-12-24 @ 7:35 PM
Ignite Modification Date: 2026-02-26 @ 12:41 AM
Study NCT ID: NCT03228303
Status: UNKNOWN
Last Update Posted: 2017-10-10
First Post: 2017-07-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Nilotinib Versus Imatinib in Treatment of Patients With Newly Diagnosed Chronic Myeloid Leukemia
Sponsor: Assiut University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: Jgmaxwell
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators